A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma

2017 ◽  
Vol 155 ◽  
pp. 93-103 ◽  
Author(s):  
Qingqing Xiong ◽  
Mangmang Cui ◽  
Yang Bai ◽  
Yuanyuan Liu ◽  
Di Liu ◽  
...  
2020 ◽  
Vol 117 ◽  
pp. 111261
Author(s):  
Jingjing Wang ◽  
Ying Qian ◽  
Liu Xu ◽  
Yurou Shao ◽  
Hu Zhang ◽  
...  

2018 ◽  
Vol Volume 13 ◽  
pp. 1539-1552 ◽  
Author(s):  
Yu Xia ◽  
Min Guo ◽  
Tiantian Xu ◽  
Yinghua Li ◽  
Changbing Wang ◽  
...  

2021 ◽  
Vol 11 ◽  
Author(s):  
Xinyao Hu ◽  
Hua Zhu ◽  
Yang Shen ◽  
Xiaoyu Zhang ◽  
Xiaoqin He ◽  
...  

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Sorafenib is approved by the U.S. Food and Drug Administration to be a first-line chemotherapy agent for patients with advanced HCC. A portion of advanced HCC patients can benefit from the treatment with sorafenib, but many patients ultimately develop sorafenib resistance, leading to a poor prognosis. The molecular mechanisms of sorafenib resistance are sophisticated and indefinite. Notably, non-coding RNAs (ncRNAs), which include long ncRNAs (lncRNAs), microRNAs (miRNAs) and circular RNAs (circRNAs), are critically participated in the occurrence and progression of tumors. Moreover, growing evidence has suggested that ncRNAs are crucial regulators in the development of resistance to sorafenib. Herein, we integrally and systematically summarized the molecular mechanisms and vital role of ncRNAs impact sorafenib resistance of HCC, and ultimately explored the potential clinical administrations of ncRNAs as new prognostic biomarkers and therapeutic targets for HCC.


HPB ◽  
2021 ◽  
Author(s):  
Takatsugu Matsumoto ◽  
Taku Aoki ◽  
Takayuki Shimizu ◽  
Kyung Hwa Park ◽  
Takayuki Shiraki ◽  
...  

Nano Research ◽  
2017 ◽  
Vol 10 (3) ◽  
pp. 834-855 ◽  
Author(s):  
Yang Liu ◽  
Guoyun Wan ◽  
Hua Guo ◽  
Yuanyuan Liu ◽  
Ping Zhou ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document